TREATMENT OF PARKINSON'S DISEASE: PROBLEMS WITH A PROGRESSING DISEASERINNE VK.1981; J. NEURAL TRASM.; ISSN 0300-9564; AUT; DA. 1981; VOL. 51; NO 1-2; PP. 161-174; BIBL. 4 P.Article

NEUROLEPTIC MALIGNANT SYNDROME-LIKE STATE FOLLOWING A WITHDRAWAL OF ANTIPARKINSONIAN DRUGSTORU M; MATSUDA O; MAKIGUCHI K et al.1981; J. NERV. MENT. DIS.; ISSN 0022-3018; USA; DA. 1981; VOL. 169; NO 5; PP. 324-327; BIBL. 12 REF.Article

UTILIZATION OF ANTIPARKINSON DRUGS IN NORWAY, SWEDEN, DENMARK AND FINLAND 1975-1979AQUILONIUS SM; GRANAT M; HARTVIG P et al.1981; ACTA NEUROL. SCAND.; ISSN 0001-6314; DNK; DA. 1981; VOL. 64; NO 1; PP. 47-53; BIBL. 7 REF.Article

A DRUG INFORMATION NOTE FOR PATIENTS RECEIVING ANTIPARKINSONIAN AGENTSSHEN WW.1981; HOSP. COMMUNITY PSYCHIATRY; ISSN 0022-1597; USA; DA. 1981; VOL. 32; NO 8; PP. 575; BIBL. 10 REF.Article

LE TRAITEMENT ACTUEL DE LA MALADIE DE PARKINSONDELWAIDE PJ.1981; LOUV. MED.; ISSN 0024-6956; BEL; DA. 1981; VOL. 100; NO 6; PP. 381-387; ABS. ENG; BIBL. 3 REF.Article

THE USE OF PERGOLIDE, A POTENT DOPAMINE AGONIST, IN PARKINSON'S DISEASELIEBERMAN AN; GOLDSTEIN M; NEOPHYTIDES A et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 1; PP. 70-75; BIBL. 25 REF.Article

PRESCRIPTIONS ET ANTALGIE SANS ANTALGIQUE.DEREUX JF.1977; J. SCI. MED. LILLE; FR.; DA. 1977; VOL. 95; NO 10; PP. 299-303Article

MOYENS ANTIPARKINSONIENS RECENTS (DOPA-L ET AMANTADINE) ET LA PSYCHIATRIE ACTUELLEDOLEZALOVA B; VACEK J.1976; CESKOSL. PSYCHIATR.; CESKOSL.; DA. 1976; VOL. 72; NO 6; PP. 403-407; ABS. RUSSE ANGL.; BIBL. 14 REF.Article

BROMOCRIPTINE AND LISURIDE IN PARKINSON DISEASELIEBERMAN AN; GOVINDAN GOPINATHAN; NEOPHYTIDES A et al.1983; ANNALS OF NEUROLOGY; ISSN 0364-5134; USA; DA. 1983; VOL. 13; NO 1; PP. 44-47; BIBL. 16 REF.Article

RECENT ADVANCES IN THE TREATMENT OF PARKINSON'S DISEASE: THE ROLE OF BROMOCRIPTINELE WITT PA; CALNE DB.1981; J. NEURAL TRANSM.; ISSN 0300-9564; AUT; DA. 1981; VOL. 51; NO 1-2; PP. 175-184; BIBL. 2 P.Article

BROMOCRIPTINE: LOW-DOSE THERAPY IN PARKINSON DISEASETEYCHENNE PF; BERGSRUD D; RACY A et al.1982; NEUROLOGY; ISSN 0028-3878; USA; DA. 1982; VOL. 32; NO 6; PP. 577-583; BIBL. 25 REF.Article

SENILE PARKINSONISM, A SURVEY OF CURRENT TREATMENTWHITE NJ; BARNES TRE.1981; AGE & AGEING; ISSN 0002-0729; GBR; DA. 1981; VOL. 10; NO 2; PP. 81-86; BIBL. 11 REF.Article

INTERESSE CLINICO DEL TEST ELETTRORETINOGRAFICO NEL MORBO DI PARKINSON = INTERET CLINIQUE DU TEST ELECTRORETINOGRAPHIQUE DANS LA MALADIE DE PARKINSONCAVALLACCI G; PEROSSINI M.1980; MINERVA OFTALMOL.; ITA; DA. 1980; VOL. 22; NO 1; PP. 1-5; ABS. ENG; BIBL. 17 REF.Article

THE EFFECT OF BROMOCRIPTINE (BCT) ON THE ON-OFF PHENOMENONGLANTZ R; GOETZ CG; NAUSIEDA PA et al.1981; J. NEURAL TRANSM.; ISSN 0300-9564; AUT; DA. 1981; VOL. 52; NO 1-2; PP. 41-47; BIBL. 14 REF.Article

MORTALITAET BEIM PARKINSONSYNDROM UND IHRE BEEINFLUSSUNG DURCH L-DOPA = MORTALITE AU COURS DE LA MALADIE DE PARKINSON. INFLUENCE DE LA L-DOPASCHNEIDER E; FISCHER PA; JACOBI P et al.1981; FORTSCHR. NEUROL. PSYCHIATR. IHRER GRENZGEB.; ISSN 0015-8194; DEU; DA. 1981; VOL. 49; NO 5; PP. 187-192; ABS. ENG; BIBL. 29 REF.Article

THERAPEUTIC ANTAGONISM BETWEEN ANTICHOLINERGIC ANTIPARKINSONISM AGENTS AND NEUROLEPTICS IN SCHIZOPHRENIA: IMPLICATIONS FOR A NEUROPHARMACOLOGICAL MODELMAN MOHAN SINGH; KAY SR.1979; NEUROPSYCHOBIOLOGY; CHE; DA. 1979; VOL. 5; NO 2; PP. 74-86; BIBL. 2 P.Article

ABUSE OF THE ANTIPARKINSON DRUGS: A REVIEW OF THE LITERATURESMITH JM.1980; J. CLIN. PSYCHIATRY; ISSN 0160-6689; USA; DA. 1980; VOL. 41; NO 10; PP. 351-354; BIBL. 24 REF.Article

DRUG THERAPY: BROMOCRIPTINEPARKES D.1979; NEW ENGL. J. MED.; USA; DA. 1979; VOL. 301; NO 16; PP. 873-878; BIBL. 44 REF.Article

TRIHEXYPHENIDYL ABUSE FOR EUPHORIGENIC EFFECTGOGGIN DA; SOLOMON GF.1979; AMER. J. PSYCHIATRY; USA; DA. 1979; VOL. 136; NO 4A; PP. 459-460; BIBL. 9 REF.Article

LEVODOPA-INDUCED ACUTE NON-HEMOLYTIC ANEMIA.ALKALAY I; ZIPOLI T.1977; ANN. ALLERGY; U.S.A.; DA. 1977; VOL. 39; NO 3; PP. 191; BIBL. 5 REF.Article

ANTICHOLINERGIC AND MEMBRANE ACTIVITIES OF AMANTADINE IN NEUROMUSCULAR TRANSMISSION.NASTUK WL; SU PC; DOUBILET P et al.1976; NATURE; G.B.; DA. 1976; VOL. 264; NO 5581; PP. 76-79; BIBL. 11 REF.Article

DRUG-INDUCED ASTERIXIS IN PARKINSON DISEASEGLANTZ R; WEINER WJ; GOETZ CG et al.1982; NEUROLOGY; ISSN 0028-3878; USA; DA. 1982; VOL. 32; NO 5; PP. 553-555; BIBL. 13 REF.Article

IMPROVED CONTROL OF BRITTLE PARKINSONISM BY SEPARATE ADMINISTRATION OF LEVODOPA AND BENSERAZIDEMCLELLAN DL; DEAN BC.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 6321; PP. 1001-1002Article

PARKINSON'S DISEASE CONCEPTS AND PROSPECTS. SYMPOSIUM. PROCEEDINGS; GRONINGEN; 1977.1977; EXCERPTA MED., INTERNATION, CONGR. SER.; PAYS-BAS; DA. 1977; NO 429; PP. 1-121; BIBL. DISSEM.Conference Paper

DOSAGE FLUORIMETRIQUE DU CHLORHYDRATE DE TRIHEXYPHENIDYLE ET DE QUELQUES DERIVES DE STRUCTURE ANALOGUE.GELBCKE M.1976; J. PHARM. BELG.; BELG.; DA. 1976; VOL. 31; NO 4; PP. 397-402; ABS. ANGL. NEERL.; BIBL. 17 REF.Article